论文信息 - A phase 1 trial of NY‐ESO‐1‐specific TCR‐engineered T‐cell therapy combined with a lymph node‐targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma - 字舞流文

A phase 1 trial of NY‐ESO‐1‐specific TCR‐engineered T‐cell therapy combined with a lymph node‐targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma

A. Matsumine | T. Sasada | H. Shiku | Hiroyoshi Hattori | Y. Nishida | A. Kawai | Takashi Watanabe | M. Emori | Y. Matsumoto | K. Takada | D. Muraoka | S. Kitano | Eiichi Sato | Y. Miyahara | N. Seo | M. Endo | S. Kageyama | Y. Nagata | M. Ishihara | N. Harada | Tomomi Yamada | F. Momose | S. Kakunaga | Shigeki Kakunaga